Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 2056

as introduced - 92nd Legislature (2021 - 2022) Posted on 03/17/2021 12:42pm

KEY: stricken = removed, old language.
underscored = added, new language.

Bill Text Versions

Engrossments
Introduction Posted on 03/09/2021

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13
1.14 1.15

A bill for an act
relating to insurance; limiting co-payments for prescription drugs and related
medical supplies prescribed to treat a chronic disease; proposing coding for new
law in Minnesota Statutes, chapter 62Q.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

new text begin [62Q.481] CO-PAYMENTS FOR PRESCRIPTION DRUGS TO TREAT
CHRONIC DISEASE.
new text end

new text begin Subdivision 1. new text end

new text begin Co-payment limit. new text end

new text begin A health plan that imposes co-payments on the
coverage of prescription drugs must limit the amount of any co-payment to $25 per
one-month supply for prescription drugs prescribed to treat a chronic disease and related
medical supplies necessary to administer the prescription drugs.
new text end

new text begin Subd. 2. new text end

new text begin Definition of chronic disease. new text end

new text begin For purposes of this section, "chronic disease"
means diabetes, asthma, and allergies requiring the use of epinephrine auto-injectors.
new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective January 1, 2022, and applies to health
plans offered, issued, and renewed on or after that date.
new text end